Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.
Octavia Y, Kararigas G, de Boer M, Chrifi I, Kietadisorn R, Swinnen M, Duimel H, Verheyen FK, Brandt MM, Fliegner D, Cheng C, Janssens S, Duncker DJ, Moens AL.
Octavia Y, et al. Among authors: duncker dj.
J Cell Mol Med. 2017 Dec;21(12):3277-3287. doi: 10.1111/jcmm.13231. Epub 2017 Jun 13.
J Cell Mol Med. 2017.
PMID: 28608983
Free PMC article.